Tharimmune Inc (NAS:THAR)
$ 2.3523 -0.1277 (-5.15%) Market Cap: 2.70 Mil Enterprise Value: -160,000.00 PE Ratio: 0 PB Ratio: 0.38 GF Score: 22/100

Hillstream BioPharma Inc at ThinkEquity Conference Transcript

Oct 26, 2022 / 07:30PM GMT
Release Date Price: $247.5 (+2.29%)
Ryan Starks
Century - Analyst

Welcome back. My name is [Ryan Starks] from a partner and life science practice leader for [Century]. Century is a full-service accounting, valuation and advisory firm supporting companies as they make their way through the capital markets.

I'm here to introduce Randy Milby, CEO of Hillstream BioPharma.

Randy Milby
Hillstream BioPharma, Inc. - CEO & Chairman

Thank you.

Well, welcome, everyone. I hope you had some cookies to give us a little bit of a sugar load before my presentation. To introduce, I am the Founder and CEO of Hillstream BioPharma. I will be making some forward-looking statements today. I do encourage you to go to our website, look at our SEC filings.

I want you to see this corporate mission and take a focus on a couple of keywords here. Drug resistance as well as devastating rare cancers. These are more than just words to me. This corporate mission is also my personal mission.

When I was a CEO of CorMedix, another publicly traded company. I licensed this technology from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot